Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Prostate Cancer and Prostatic Diseases|February 19, 2021
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetateRosario F Di Stefano, Marcello Tucci, Fabio Turco, et al.
Cells|August 28, 2024
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective AnalysisGiovanni Farinea, Mariangela Calabrese, Federica Carfì, et al.
Minerva Urology and Nephrology|February 11, 2022
Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective studyTiziana Angusti, Rosario F DI Stefano, Antonella Parente, et al.
Cancers|April 26, 2025
Metastasis-Directed Therapy in Oligometastatic Prostate Cancer: Biological Rationale and Systematic Review of Published DataFrancesco Fiorica, Teodoro Sava, Jacopo Giuliani, et al.
International Journal of Molecular Sciences|January 11, 2024
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate CancerMariangela Calabrese, Isabella Saporita, Fabio Turco, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 15, 2020
Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamideConsuelo Buttigliero, Marcello Tucci, Cristina Sonetto, et al.
Cancer Treatment Reviews|February 10, 2019
Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE eraMarcello Tucci, Orazio Caffo, Consuelo Buttigliero, et al.
Cells|May 28, 2022
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?Marco Audisio, Consuelo Buttigliero, Fabio Turco, et al.
Prostate Cancer and Prostatic Diseases|July 12, 2020
The prognostic value of pain in castration-sensitive prostate cancerRoberto Iacovelli, Chiara Ciccarese, Orazio Caffo, et al.
Human Pathology|June 26, 2016
Androgen deprivation modulates gene expression profile along prostate cancer progressionMarco Volante, Daniele Tota, Jessica Giorcelli, et al.
Pageof 9